Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

China flag against blue sky
Biotech

China looks to ban foreign acquisitions of key biotech platforms

Beijing is looking to block foreign acquisitions of proprietary cell and gene therapy, siRNA and pathogen gain-of-function platforms.
Angus Liu Oct 16, 2026 10:38am
Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o

Bausch + Lomb CEO heads for exit once more—Chutes & Ladders

Oct 16, 2026 8:30am
iRegene Therapeuticss NouvSight001 Cleared for Clinical Trials in the US and China for Retinitis Pigmentosa

iRegene Therapeutics’s NouvSight001 Cleared for Clinical Trials in the U.S. and China for Retinitis Pigmentosa

Brought to you by iRegene Therapeutics
Boston Harbor skyline

How Boston biotechs cope with shallower pool of seed funding

Oct 16, 2026 7:00am
video
How AI is reshaping biopharma decision-making

How AI is reshaping biopharma decision-making

Brought to you by Clarivate
Estuary river tributary

Estuary emerges with $103M for kidney disease gene therapies

Oct 16, 2026 6:30am